✦ LIBER ✦

The 12-month safety profile of dexlansoprazole, a proton pump inhibitor with a dual delayed release formulation, in patients with gastro-oesophageal reflux disease

✍ Scribed by A. H. Dabholkar; C. Han; M. M. Paris; M. C. Perez; S. N. Atkinson; D. A. Peura

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety profile of dexlansoprazole MR, a

✍ D. A. PEURA; D. C. METZ; A. H. DABHOLKAR; M. M. PARIS; P. YU; S. N. ATKINSON 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB

Clinical trials: healing of erosive oeso

✍ P. SHARMA; N. J. SHAHEEN; M. C. PEREZ; B. L. PILMER; M. LEE; S. N. ATKINSON; D. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

Clinical trial: dexlansoprazole MR, a pr

✍ D. C. METZ; C. W. HOWDEN; M. C. PEREZ; L. LARSEN; J. O’NEIL; S. N. ATKINSON 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB

Systematic review: the association betwe

✍ A. Becher; H. El-Serag 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB